Rigshospitalet and Roche Diagnostics Denmark have established a long‑term strategic partnership aimed at designing and implementing effective and sustainable solutions that help deliver more targeted treatments, avoid unnecessary examinations, and improve outcomes for patients.
The partnership is founded on a shared ambition: to address some of the most significant challenges facing modern healthcare, such as increasing demand, rising complexity in diagnostics and treatment, and a growing need for digital, data‑driven solutions. By combining Rigshospitalet's highly specialized clinical environment with Roche's global expertise in diagnostics, digital health, and research, the collaboration seeks to accelerate the development and validation of solutions that create real value for patients and the wider healthcare system.
Purpose and vision of the partnership
The partnership has been established to enable faster development, testing, and implementation of new technologies and methods that can improve diagnostics, treatment pathways, and patient outcomes.
The partnerships purpose is to:
- Support innovation that benefits patients, including more precise and timely diagnoses, more personalized treatment options, and improved care pathways.
- Contribute to a sustainable healthcare system, where advanced technologies help free up staff resources, streamline workflows, and secure better use of data.
- Strengthen Denmark's role in global health innovation, ensuring that new solutions are developed, validated, and scaled in a real clinical setting.
Through the partnership, Rigshospitalet will serve as a test center for Roche's new clinically relevant digital and technological solutions, as well as diagnostic tests that can be scaled and thereby benefit patients across the Danish healthcare system and internationally.
The collaboration is anchored in Rigshospitalet's mission to contribute to the development of the entire healthcare system together with national and international partners — and in Roche's long-standing commitment to advancing diagnostics, personalized medicine, and data-driven health solutions.
Built on many years of successful cooperation, the partnership is founded on trust, aligned ambitions, and a shared commitment to creating value for patients and ensuring a future‑ready, sustainable healthcare system.